Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Secret_Agent_Man who wrote (548)	1/23/2000 11:02:00 PM
From: Torben Noerup Nielsen	Read Replies (2) \| Respond to of 52153

All, What's the prevailing opinion on Corixa? I'm looking more and more at companies that work to boost the immune system in various ways and this one looks good but maybe a bit pricey. Then again, if they do well, todays price won't matter a whole lot. Richard, I presume you noticed that they're working with SmithKline Beecham on a vaccine for RSV. It includes their adjuvant. What do you think of this in relation to ViroPharma? Hopefully you didn't work for them or any of the companies they've recently gobbled up as a consultant too :-) Thanks, Torben P.S. I liked their web page by the way. It was nicely done. Professional and helpful. To most of you, this is probably irrelevant, but I like to be able to jump to a company's web page and see a well organized one that's kept up to date. It also needs to contain facts, not hype. This one qualifies. Yes, it's probably a strange criterion, but when someone puts up a web page that's shoddy or doesn't have up to date information on it, I take that as a lack of regard for investors. P.P.S. I read the Wall Street Transcript interview with their CEO. I liked the way he came across. Anyone else have thoughts on him?